http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022260436-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0861703061dfbfa74c00c717f07953
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
filingDate 2022-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431731b5bc98ecb5030067ca29d2e42e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9d0bbf808759c15b1c5ae21e96c5b1
publicationDate 2022-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022260436-A1
titleOfInvention Microfluidic chip including tumor spheroids
abstract The present invention relates to a microfluidic device, a method for culturing cells in the microfluidic device, and a drug screening method, wherein the microfluidic device provides an environment suitable for tumor spheroids by imitating the structure and function of 2-dimensional-3-dimensional connective tissue or 3-dimensional spheroids and blood vessels, and thus can be used in place of animal models as an in vitro model for developing targeted treatments for cancer and new drugs or the like.
priorityDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200124449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019032021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210038110-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016313306-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54320
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07916
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99372
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103183906

Total number of triples: 52.